Wadhane Jitendra - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 26, 2024, Wadhane Jitendra's relationship to Pyxis Oncology, Inc. (PYXS) is Officer (SVP, Chief Accounting Officer), and currently has 398,421 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PYXS insiders.
Data Source: SEC.
Wadhane Jitendra - Insider Non-Derivative Transactions of PYXS Common Stock
Wadhane Jitendra - Insider Non-Derivative Transactions at PYXS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 27, 2024 | Acquisition -- (Common Stock) | 131484 | 0 | 398421 |
| Nov 16, 2023 | Acquisition -- (Common Stock) | 40000 | 0 | 266937 |
| Sep 28, 2023 | P -- (Common Stock) | 2500 | 1.87 | 226937 |
| Sep 26, 2023 | P -- (Common Stock) | 5000 | 1.77 | 224437 |
| Sep 23, 2023 | P -- (Common Stock) | 2500 | 1.74 | 219437 |
| Sep 8, 2023 | Acquisition -- (Common Stock) | 93896 | 0 | 211937 |
| Mar 25, 2023 | Acquisition -- (Common Stock) | 45000 | 0 | 88648 |
| Mar 25, 2023 | Acquisition -- (Common Stock) | 29393 | 0 | 118041 |